Search research articles
Contact Us
Filters
Showing results (391-400 of 411) with videos related to
Page
of 42
Sort By:
Acta Endocrinologica
|
December 1, 1982
Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol
J Reeve, M Tellez, J R Green, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
August 28, 2009
Ultrasound guidance versus electrical stimulation for infraclavicular brachial plexus perineural catheter insertion
Edward R Mariano, Vanessa J Loland, Richard H Bellars, et al.
La Revue De Medecine Interne
|
March 28, 2006
[Phototype, vitamin D status and bone mineral density among women at risk of osteoporosis]
C Guinot, K Ezzedine, E Mauger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group
R P Tonino, P J Meunier, R Emkey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2002
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial
P J Meunier, D O Slosman, P D Delmas, et al.
Arthritis and Rheumatism
|
June 3, 2008
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial
Jean-Yves Reginster, Dieter Felsenberg, Steven Boonen, et al.
The New England Journal of Medicine
|
January 30, 2004
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
Pierre J Meunier, Christian Roux, Ego Seeman, et al.
British Medical Journal
|
June 7, 1980
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial
J Reeve, P J Meunier, J A Parsons, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2005
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
J Y Reginster, E Seeman, M C De Vernejoul, et al.
Regional Anesthesia and Pain Medicine
|
September 26, 2025
Percutaneous analgesic device enabling both local anesthetic delivery and electrical stimulation (neuromodulation) of peripheral nerves: a pilot feasibility study (case series)
Brian M Ilfeld, Engy T Said, Brian H Park, et al.
Page
of 42
Search research articles
Search
Showing results (391-400 of 411) with videos related to
Sort By:
Page
of 42
Acta Endocrinologica
|
December 1, 1982
Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol
J Reeve, M Tellez, J R Green, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
August 28, 2009
Ultrasound guidance versus electrical stimulation for infraclavicular brachial plexus perineural catheter insertion
Edward R Mariano, Vanessa J Loland, Richard H Bellars, et al.
La Revue De Medecine Interne
|
March 28, 2006
[Phototype, vitamin D status and bone mineral density among women at risk of osteoporosis]
C Guinot, K Ezzedine, E Mauger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group
R P Tonino, P J Meunier, R Emkey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2002
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial
P J Meunier, D O Slosman, P D Delmas, et al.
Arthritis and Rheumatism
|
June 3, 2008
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial
Jean-Yves Reginster, Dieter Felsenberg, Steven Boonen, et al.
The New England Journal of Medicine
|
January 30, 2004
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
Pierre J Meunier, Christian Roux, Ego Seeman, et al.
British Medical Journal
|
June 7, 1980
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial
J Reeve, P J Meunier, J A Parsons, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2005
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
J Y Reginster, E Seeman, M C De Vernejoul, et al.
Regional Anesthesia and Pain Medicine
|
September 26, 2025
Percutaneous analgesic device enabling both local anesthetic delivery and electrical stimulation (neuromodulation) of peripheral nerves: a pilot feasibility study (case series)
Brian M Ilfeld, Engy T Said, Brian H Park, et al.
Page
of 42